DRI Healthcare Trust
Research DRI Healthcare Trust (DHT-U) on Bullrun: market cap USD 684.95M, dividend yield 3.3%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerDHT-U
- ExchangeTO
- CountryCanada
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyUSD
- Market capUSD 684.95M
- Dividend yield3.3%
- Financial periodQ2 2026
- RevenueUSD 41.50M
- Net incomeUSD 6.02M
- Free cash flowUSD 33.60M
Valuation Snapshot
latest market cap is USD 684.95M; dividend yield is 3.3%.
Peer valuation comparison
Latest dividend yield is 3.34% versus a Healthcare sector median of 2.11% (58.3% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 152.93M | -USD 50.47M | USD 21.96M | n/a | n/a | USD 42.43M | USD 376.06M | USD 438.58M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-10 | USD 684.95M | n/a | 3.4% | 0.42 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.42 USD, yield 3.3%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.4 USD |
About DRI Healthcare Trust
DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is DRI Healthcare Trust's market cap?
DRI Healthcare Trust's market capitalization is USD 684.95M.
Does DRI Healthcare Trust pay a dividend?
DRI Healthcare Trust has a dividend yield of 3.3%.
What does DRI Healthcare Trust do?
DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.